Sarcopenic Obesity
The year in obesity: New data on semaglutide and tirzepatide, sarcopenic obesity and more
New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering glucose levels and body weight.
Multidisciplinary WCIRDC meeting honors cardiometabolic research pioneer
The 20th annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease will offer a unique blend of basic and clinical science across cardiometabolic disciplines while also providing practical implications for patient care.
Obesity plus low muscle mass may increase CKD risk in type 2 diabetes
Sarcopenic obesity may increase the risk for chronic kidney disease among adults with type 2 diabetes, but low muscle mass without obesity was not associated with CKD, according to study results published in Obesity.
Calf circumference predicts falls in older patients on hemodialysis
Calf circumference, higher BMI and age are predictors of falls among older patients on hemodialysis, according to data published in the Journal of Renal Nutrition.
Renal decline risk increased with sarcopenia in type 2 diabetes, obesity
Among adults with type 2 diabetes, estimated glomerular filtration rate may fall to a greater degree if a patient also has sarcopenia and obesity, according to findings published in Diabetic Medicine.